vs
FIRST MID BANCSHARES, INC.（FMBH）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
FIRST MID BANCSHARES, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$88.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 26.8%，领先357.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 3.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.0%）
First Mid Bancshares Inc.是一家总部位于美国的区域性金融服务控股公司，提供全品类零售与商业银行产品、财富管理、保险解决方案及农业融资服务，主要服务伊利诺伊、密苏里、印第安纳等美国中西部州的个人、中小企业及农业客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FMBH vs RIGL — 直观对比
营收规模更大
FMBH
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出17.8%
3.4%
净利率更高
RIGL
高出357.2%
26.8%
两年增速更快
RIGL
近两年复合增速
5.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $88.2M | $69.8M |
| 净利润 | $23.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 34.0% | 33.2% |
| 净利率 | 26.8% | 384.0% |
| 营收同比 | 3.4% | 21.2% |
| 净利润同比 | 23.5% | 1769.2% |
| 每股收益（稀释后） | $0.98 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMBHRIGL
| Q4 25 | $88.2M | $69.8M | ||
| Q3 25 | $89.3M | $69.5M | ||
| Q2 25 | $87.5M | $101.7M | ||
| Q1 25 | $84.3M | $53.3M | ||
| Q4 24 | $85.3M | $57.6M | ||
| Q3 24 | $80.6M | $55.3M | ||
| Q2 24 | $79.2M | $36.8M | ||
| Q1 24 | $79.9M | $29.5M |
净利润FMBHRIGL
| Q4 25 | $23.7M | $268.1M | ||
| Q3 25 | $22.5M | $27.9M | ||
| Q2 25 | $23.4M | $59.6M | ||
| Q1 25 | $22.2M | $11.4M | ||
| Q4 24 | $19.2M | $14.3M | ||
| Q3 24 | $19.5M | $12.4M | ||
| Q2 24 | $19.7M | $-1.0M | ||
| Q1 24 | $20.5M | $-8.2M |
毛利率FMBHRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FMBHRIGL
| Q4 25 | 34.0% | 33.2% | ||
| Q3 25 | 32.2% | 40.9% | ||
| Q2 25 | 34.4% | 60.1% | ||
| Q1 25 | 33.4% | 23.9% | ||
| Q4 24 | 29.7% | 28.9% | ||
| Q3 24 | 31.5% | 25.4% | ||
| Q2 24 | 33.7% | 1.2% | ||
| Q1 24 | 33.7% | -23.6% |
净利率FMBHRIGL
| Q4 25 | 26.8% | 384.0% | ||
| Q3 25 | 25.2% | 40.2% | ||
| Q2 25 | 26.8% | 58.6% | ||
| Q1 25 | 26.3% | 21.5% | ||
| Q4 24 | 22.5% | 24.9% | ||
| Q3 24 | 24.2% | 22.5% | ||
| Q2 24 | 24.9% | -2.8% | ||
| Q1 24 | 25.6% | -27.9% |
每股收益（稀释后）FMBHRIGL
| Q4 25 | $0.98 | $14.11 | ||
| Q3 25 | $0.94 | $1.46 | ||
| Q2 25 | $0.98 | $3.28 | ||
| Q1 25 | $0.93 | $0.63 | ||
| Q4 24 | $0.81 | $0.82 | ||
| Q3 24 | $0.81 | $0.70 | ||
| Q2 24 | $0.82 | $-0.06 | ||
| Q1 24 | $0.86 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $354.5M | $52.5M |
| 股东权益账面价值 | $958.7M | $391.5M |
| 总资产 | $8.0B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.37× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FMBHRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务FMBHRIGL
| Q4 25 | $354.5M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益FMBHRIGL
| Q4 25 | $958.7M | $391.5M | ||
| Q3 25 | $932.2M | $117.6M | ||
| Q2 25 | $894.1M | $81.9M | ||
| Q1 25 | $870.9M | $18.6M | ||
| Q4 24 | $846.4M | $3.3M | ||
| Q3 24 | $858.5M | $-14.6M | ||
| Q2 24 | $813.6M | $-29.9M | ||
| Q1 24 | $798.0M | $-31.7M |
总资产FMBHRIGL
| Q4 25 | $8.0B | $513.6M | ||
| Q3 25 | $7.8B | $242.5M | ||
| Q2 25 | $7.7B | $206.7M | ||
| Q1 25 | $7.6B | $176.0M | ||
| Q4 24 | $7.5B | $164.0M | ||
| Q3 24 | $7.6B | $139.4M | ||
| Q2 24 | $7.6B | $128.4M | ||
| Q1 24 | $7.7B | $126.5M |
负债/权益比FMBHRIGL
| Q4 25 | 0.37× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $130.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $124.0M | — |
| 自由现金流率自由现金流/营收 | 140.6% | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | 5.53× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $207.9M | — |
8季度趋势，按日历期对齐
经营现金流FMBHRIGL
| Q4 25 | $130.9M | $22.0M | ||
| Q3 25 | $33.0M | $24.0M | ||
| Q2 25 | $7.7M | $30.5M | ||
| Q1 25 | $47.9M | $-893.0K | ||
| Q4 24 | $124.4M | $14.5M | ||
| Q3 24 | $33.1M | $21.7M | ||
| Q2 24 | $24.0M | $302.0K | ||
| Q1 24 | $29.0M | $-5.0M |
自由现金流FMBHRIGL
| Q4 25 | $124.0M | — | ||
| Q3 25 | $31.9M | — | ||
| Q2 25 | $6.0M | — | ||
| Q1 25 | $46.0M | — | ||
| Q4 24 | $119.5M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $22.9M | — | ||
| Q1 24 | $27.6M | — |
自由现金流率FMBHRIGL
| Q4 25 | 140.6% | — | ||
| Q3 25 | 35.8% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 54.5% | — | ||
| Q4 24 | 140.0% | — | ||
| Q3 24 | 39.7% | — | ||
| Q2 24 | 28.9% | — | ||
| Q1 24 | 34.5% | — |
资本支出强度FMBHRIGL
| Q4 25 | 7.8% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.9% | — |
现金转化率FMBHRIGL
| Q4 25 | 5.53× | 0.08× | ||
| Q3 25 | 1.47× | 0.86× | ||
| Q2 25 | 0.33× | 0.51× | ||
| Q1 25 | 2.16× | -0.08× | ||
| Q4 24 | 6.49× | 1.01× | ||
| Q3 24 | 1.70× | 1.75× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
